37 results
8-K
PNT
POINT Biopharma Global Inc.
13 Jun 23
Departure of Directors or Certain Officers
4:45pm
on the Company’s Nominating and Corporate Governance Committee.
Dr. Martell is a pharmaceutical executive. She started her pharmaceutical career at Pfizer
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
Inspections 100 Part III 101 Item 10. Directors, Executive Officers and Corporate Governance 101 Item 11. Executive Compensation 101 Item 12. Security … in governance and reporting requirements, which could further increase costs. Because POINT has significant operations in Canada, it may be difficult
424B3
wcwbvbnkiz0f
11 Jul 22
Prospectus supplement
4:32pm
POS AM
jvkwvzc1frhmcyzzl
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
DEF 14A
s5vmato8ude3tjff
28 Apr 22
Definitive proxy
8:36am
424B3
nwayzhr4uxqemc3 0462
31 Mar 22
Prospectus supplement
11:42am
POS AM
u3cn kr5wiqfdgh
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
oz7vvf57n02sqnjht
5 Aug 21
Prospectus supplement
4:26pm
8-K
EX-3.2
ciu1iy 4xmin915
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
fjp0zj
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
424B3
z8n41szzqskc
9 Jun 21
Prospectus supplement
4:42pm